Noa Davis
Tel Aviv University
7 Papers
46 Citations
Noa Davis is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Population & PAX6. The author has an hindex of 6, co-authored 7 publications.
Chat about Author
Papers
Pax6 dosage requirements in iris and ciliary body differentiation.
Noa Davis,Chen Yoffe,Shaul Raviv,Ran Antes,Joachim Berger,Silvia Holzmann,Anastassia Stoykova,Paul A. Overbeek,Ernst R. Tamm,Ruth Ashery-Padan +9 more
TL;DR: These findings demonstrate the dosage-sensitive roles of Pax6 in the formation of both the CB and the iris, and employ a modular system that includes null and overexpressed conditional alleles of Pax 6.
68
Reduced expression of Pax6 in lens and cornea of mutant mice leads to failure of chamber angle development and juvenile glaucoma
Markus Kroeber,Noa Davis,Silvia Holzmann,Michaela Kritzenberger,Michal Shelah-Goraly,Ron Ofri,Ruth Ashery-Padan,Ernst R. Tamm +7 more
TL;DR: It is concluded that the defects in iridocorneal angle formation are caused by non-autonomous mechanisms due to Pax6 haploinsufficiency in lens or corneal epithelial cells, and Pax6 probably controls the expression of signaling molecules in lens cells that regulate the morphogenetic processes during iridOCorneal angles formation.
SIRT1/HERC4 Locus Associated With Bisphosphonate-Induced Osteonecrosis of the Jaw: An Exome-Wide Association Analysis.
Guang Yang,Issam Hamadeh,Joseph Katz,Alberto Riva,Peter L. Lakatos,Bernadett Balla,János P. Kósa,Mihály Vaszilkó,Gian Andrea Pelliccioni,Noa Davis,Taimour Y. Langaee,Jan S. Moreb,Yan Gong +12 more
TL;DR: The SIRT1/HERC4 locus on chromosome 10 to be associated with iv BP‐induced ONJ and two promoter SNPs that might be the potential genetic markers for this association are identified.
36
Pd19-09 performance of a novel urine-based biomarker for the monitoring of bladder cancer recurrence
Ofer Nativ,Sarel Halachmi,Kohava Biton,Marina Zlotnik,Chen Yoffe,Noa Davis,Yael Glickman,Jacob Bejar +7 more
TL;DR: The HYMN trial did not show an overall difference between RITE and the control arm, however, there was a benefit for RITE in participants with papillary-only disease and RITE was well tolerated with comparable adverse events compared with BCG.
2
The prevalence and expression of inherited connexin 26 mutations associated with nonsyndromic hearing loss in the Israeli population.
Tama Sobe,Sarah Vreugde,Hashem Shahin,Mira Berlin,Noa Davis,Moien Kanaan,Yuval Yaron,Avi Orr-Urtreger,Moshe Frydman,Mordechai Shohat,Karen B. Avraham +10 more
TL;DR: The results suggest that, in Israel, clinicians should first screen for the common 167delT and 35delG mutations by simple and inexpensive restriction enzyme analysis, although if these are not found, sequencing should be done to rule out additional mutations due to the ethnic diversity in this region.